The LCTR-Series of Laminar Continuous Flow Chemical Reactors from Analytik set a new standard for high yield synthesis of high-purity, uniform substances based upon the Taylor fluid flow principle
Testa Analytical Solutions e.K reports on the development and supply of key detector components for ACOMP, a smart manufacturing system by Fluence Analytics that continuously analyzes polymers during production
The DrySyn Spiral Evaporator from Asynt is enabling the Cresswell Group within the Department of Chemistry at the University of Bath (UK) to improve and streamline many aspects of their synthetic organic methods development
While student activity is quieter on campus through the summer months, faculty research continues full swing at Southern Illinois University Edwardsville
Helmer Scientific, a leading manufacturer of cold storage products and processing equipment, has announced the expansion of their GX Solution Refrigerator line to include models from 13 to 56 cu ft
Shield Diagnostics, an Andreessen Horowitz-backed biotechnology company tackling antibiotic resistance by bringing precision medicine to infectious disease, announced today that it has been awarded accreditation by the College of American Pathologists (CAP)
SP Scientific (Warminster, PA, USA) announces the signing of a new partnership agreement with Lab-i-DOSiTECNO Pharma Technologies (Barcelona, Spain) enabling both companies to offer complete aseptic vial and syringe fill-finish lines lines for Injectable, Ophthalmic & Oral Products in Liquid and Powder Form.
Hamilton Thorne Ltd. (TSX-V: HTL) ("Hamilton Thorne" or the "Company"), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies ("ART") and developmental biology research markets, today announced that it has completed the acquisition (the "Transaction") of Planer Ltd. ("Planer")
binx health, the pioneer in anywhere, anytime testing for women's health, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its first-of-kind, highly sensitive and specific, molecular point-of-care (POC) diagnostic testing platform, the binx io®
LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (the “Company”), a biotechnology company that develops genetic analyzers for rapid pathogen detection and other molecular markers, announced today it has an agreement to place a beta prototype with Assurance Scientific Laboratories (ASL) in Vestavia, Alabama in August 2019
|
|
|
|
|
|
|
|
|